Epigenomics of Cardiometabolic Diseases in Mexican Americans

墨西哥裔美国人心脏代谢疾病的表观基因组学

基本信息

批准号：
9337499
负责人：
Bertha Hidalgo
金额：
$ 14.21万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-09-01 至 2020-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9337499
关键词：
Address Adenine Nucleotides Adult Affect Age Aging Blood Pressure Body fat Candidate Disease Gene Cohort Analysis Cohort Studies Cytosine Nucleotides DNA Methylation Data Data Set Development Diabetes Mellitus Disease Dyslipidemias Environmental Exposure Environmental Risk Factor Epigenetic Process Family Fasting Fostering Gene Expression Genes Genetic Genetic Polymorphism Genomics Glucose Goals Health Health Care Costs Heart Heredity Hispanics Hypertension Individual Insulin Investigation K-Series Research Career Programs Knowledge Latino Malignant Neoplasms Mediator of activation protein Mentors Metabolic Methods Methylation Mexican Americans Modeling Modification Non-Insulin-Dependent Diabetes Mellitus Nucleotides Obesity Outcome Pathway interactions Phenotype Play Positioning Attribute Prevalence Principal Investigator Prospective cohort Prospective cohort study Regulation Research Research Training Risk Risk Factors Role Sampling Scientist Single Nucleotide Polymorphism Site Susceptibility Gene Syndrome TXNIP gene Time Triglycerides Variant Visit causal model comparative design epigenomics fasting glucose genome sequencing genome-wide health disparity insight methyl group mortality non-genetic novel programs pyrosequencing racial and ethnic skills trait waist circumference whole genome

项目摘要

DESCRIPTION (provided by applicant): Cardiometabolic syndrome (CMS) is known as the collective impact of type 2 diabetes (T2D), hypertension (HTN), and obesity, and is one of the biggest health challenges facing the world today. DNA methylation, the addition of a methyl group to cytosine or adenine nucleotides, varies with aging and with environmental exposures, and is a critical epigenetic mediator of gene expression. CMS has a variety of local and systemic manifestations, all of which are likely impacted by a combination of genetic, genomic, and epigenetic pathways. We hypothesize that characterization of gene-specific DNA methylation marks will provide important insights into the factors contributing to CMS. We also hypothesize that characterizing DNA methylation marks correlated with ABCG1, CPT1A, and TXNIP variants may provide important insights into the regulation of these key cardiometabolic genes, previously determined to be important in CMS. Thus, the broad goals of this project include three specific aims to be carried out in the San Antonio Family Heart Study (SAFHS) cohort of 600 Mexican Americans: 1) To determine the association of quantitative methylation data from ABCG1, CPT1A, and TXNIP at baseline with prevalent diabetes-, hypertension-, and obesity-related phenotypes; 2) To determine the association of quantitative methylation data from ABCG1, CPT1A, and TXNIP at baseline with progression to diabetes, hypertension, and obesity over four study visits; and 3) To integrate single nucleotide polymorphism (SNP) variation, methylation marks, and gene expression data to define the most comprehensive causal model of CMS. The expected outcome of the proposed research and training is preliminary data to inform the design of a larger study led by the applicant to assess racial/ethnic variation in the epigenetics of CMS. In summary, this Mentored Career Development Award will foster the candidate's professional development as an independent scientist by providing an opportunity to gain expertise in epigenomics, health disparities, and statistical genetics. (End of Abstract)

描述（由应用程序提供）：心脏代谢综合征（CMS）被称为2型糖尿病（T2D），高血压（HTN）和肥胖症的集体影响，并且是当今世界面临的最大健康挑战之一。 DNA甲基化，将甲基添加到胞嘧啶或腺嘌呤核苷酸中，随着衰老和环境暴露而变化，并且是基因表达的关键表观遗传介质。 CMS具有多种局部和系统的表现，所有这些表现都可能受到遗传，基因组和表观遗传途径的组合的影响。我们假设基因特异性DNA甲基化标记的表征将为促成CMS的因素提供重要的见解。我们还假设表征与ABCG1，CPT1A和TXNIP变体相关的DNA甲基化标记可能会为调节这些键心脏代谢基因的调节提供重要的见解，以前确定在CMS中很重要。这是该项目的广泛目标包括在圣安东尼奥家庭心脏研究（SAFHS）中进行的三个具体目标：600墨西哥裔美国人：1）确定基于ABCG1，CPT1A和TXNIP的定量甲基化数据的关联，并在基础上与普遍的糖尿病 - 高度，高度，高度，和obesity-obesity-obesity-obesity-eckotectipy; 2）确定基线时ABCG1，CPT1A和TXNIP的定量甲基化数据与四次研究访问的糖尿病，高血压和肥胖的进展； 3）整合单个核丁基多态性（SNP）变异，甲基化标记和基因表达数据，以定义CMS的最全面的催化模型。拟议的研究和培训的预期结果是初步数据，以告知申请人领导的一项较大研究的设计，以评估CMS表观遗传学的种族/族裔变异。总而言之，这一指导的职业发展奖将通过提供一个在表观基因组学，健康差异和统计遗传学方面的专业知识的机会来促进候选人作为独立科学家的职业发展。（抽象的结尾）